Overview of platelet physiology: Its hemostatic and nonhemostatic role in disease pathogenesis

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Ghoshal, Kakali ^a   Bhattacharyya, Maitree ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BETA3 INTEGRIN; CALCIUM; CATECHOLAMINE; CD36 ANTIGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; INSULIN; METFORMIN; SEROTONIN; SULFONYLUREA; THROMBOCYTE RECEPTOR; THROMBOXANE; VON WILLEBRAND FACTOR; HEMOSTATIC AGENT; PURINERGIC P2Y12 RECEPTOR;

ALZHEIMER DISEASE; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL RESEARCH; DIABETES MELLITUS; DNA POLYMORPHISM; DRUG EFFECT; ENDOTHELIUM; FLOW CYTOMETRY; HEART DISEASE; HEMOSTASIS; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; INSULIN RESISTANCE; KIDNEY DISEASE; LIVER DISEASE; MEMBRANE FLUIDITY; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE HYPERAGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; THROMBOCYTOPOIESIS; ULTRASTRUCTURE; METABOLISM; PHYSIOLOGY; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; HEMOSTATICS; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; RECEPTORS, PURINERGIC P2Y12;

EID: 84898853313     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/781857     Document Type: Review

References (142)

1. Ribatti D., Crivellato E., Giulio Bizzozero and the discovery of platelets. Leukemia Research 2007 31 10 1339 1341 2-s2.0-34547821918 10.1016/j.leukres.2007.02.008
2. Cerletti C., Tamburrelli C., Izzi B., Gianfagna F., de Gaetano G., Platelet-leukocyte interactions in thrombosis. Thrombosis Research 2012 129 3 263 266 2-s2.0-84857784367 10.1016/j.thromres.2011.10.010
3. Vinik A. I., Erbas T., Sun Park T., Nolan R., Pittenger G. L., Platelet dysfunction in type 2 diabetes. Diabetes Care 2001 24 8 1476 1485 2-s2.0-0035433149
4. Sharma G., Berger J. S., Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. Journal of Thrombosis and Thrombolysis 2011 32 2 201 208 2-s2.0-80052511874 10.1007/s11239-011-0590-9
5. Michelson A. D., Flow cytometry: a clinical test of platelet function. Blood 1996 87 12 4925 4936 2-s2.0-0029895895
6. Rinder H. M., P latelet function testing by flow cytometry. Clinical Laboratory Science 1998 11 365 372
7. Storey R. F., New developments in antiplatelet therapy. European Heart Journal, Supplement 2008 10 D30 D37 2-s2.0-58249133717 10.1093/eurheartj/sun008
8. Nomura S., Function and clinical significance of platelet-derived microparticles. International Journal of Hematology 2001 74 4 397 404 2-s2.0-0035751752
9. Blair P., laumenhaft R. F., P latelet alpha-granules: basic biology and clinical correlates. Blood Reviews 2009 23 177 189
10. Offermanns S., Activation of platelet function through G protein-coupled receptors. Circulation Research 2006 99 12 1293 1304 2-s2.0-33845606632 10.1161/01.RES.0000251742.71301.16
11. Heemskerk J. W., Bevers E. M., Lindhout T., P latelet activation and bloo d coagulation. Thrombosis and Haemostasis 2002 88 186 193
12. Behnke O., Forer A., From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. European Journal of Haematology, Supplement 1998 60 61 3 24 2-s2.0-0031610866
13. Michelson A. D., Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Seminars in Thrombosis and Hemostasis 1992 18 1 18 27 2-s2.0-0026597021
14. White J. G., Interaction of membrane systems in blood platelets. American Journal of Pathology 1972 66 2 295 312 2-s2.0-0015295311
15. Brass L. F., Hoxie J. A., Manning D. R., Signaling through G proteins and G protein-coupled receptors during platelet activation. Thrombosis and Haemostasis 1993 70 1 217 223 2-s2.0-0027199485
16. Flaumenhaft R., Molecular basis of platelet granule secretion. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1152 1160 2-s2.0-0038785740 10.1161/01.ATV.0000075965.88456.48
17. Diacovo T. G., Roth S. J., Buccola J. M., Bainton D. F., Springer T. A., Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the β 2- integrin CD11b/CD18. Blood 1996 88 1 146 157 2-s2.0-0029947679
18. Folkman J., Browder T., Palmblad J., Angiogenesis research: guidelines for translation to clinical application. Thrombosis and Haemostasis 2001 86 1 23 33 2-s2.0-0034924216
19. Thon J. N., Italiano J. E., P latelets: production, morphology and ultrastructure. Handbook of Experimental Pharmacology 2012 210 3 22
20. Kauskot A., Hoylaerts M. F., P latelet receptors. Handbook of Experimental Pharmacology 2012 210 23 57
21. Warkentin T. E., Aird W. C., Rand J. H., Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology 2003 497 519 2-s2.0-2942726675
22. Lin Y., Weisdorf D. J., Solovey A., Hebbel R. P., Origins of circulating endothelial cells and endothelial outgrowth from blood. Journal of Clinical Investigation 2000 105 1 71 77 2-s2.0-0033989026
23. Félétou M., Huang Y., Vanhoutte P. M., Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. British Journal of Pharmacology 2011 164 3 894 912 2-s2.0-79958056715 10.1111/j.1476-5381.2011. 01276.x
24. Corazzi T., Leone M., Maucci R., Corazzi L., Gresele P., Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). Journal of Pharmacology and Experimental Therapeutics 2005 315 3 1331 1337 2-s2.0-27744574053 10.1124/jpet.105.089896
25. Smith W. L., DeWitt D. L., Garavito R. M., Cyclooxygenases: structural, cellular, and molecular biology. Annual Review of Biochemistry 2000 69 145 182 2-s2.0-0033791318 10.1146/annurev.biochem.69.1.145
26. Patrono C., Ciabattoni G., Pinca E., Pugliese F., Castrucci G., de Salvo A., Satta M. A., Peskar B. A., Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thrombosis Research 1980 17 317 327
27. Lecka J., Rana M. S., Sévigny J., Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. British Journal of Pharmacology 2010 161 5 1150 1160 2-s2.0-77958529498 10.1111/j.1476-5381.2010.00951.x
28. Yngen M., Östenson C.-G., Li N., Hjemdahl P., Wallén N. H., Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus. Blood Coagulation and Fibrinolysis 2001 12 2 109 116 2-s2.0-0035077478 10.1097/00001721-200103000-00004
29. Munnix I. C. A., Cosemans J. M. E. M., Auger J. M., Heemskerk J. W. M., Platelet response heterogeneity in thrombus formation. Thrombosis and Haemostasis 2009 102 6 1149 1156 2-s2.0-72949093138 10.1160/TH09-05-0289
30. Badimon L., Vilahur G., Padro T., Lipoproteins, platelets and atherothrombosis. Revista Española de Cardiología 2009 62 1161 1178
31. Gryglewski R. J., Botting R. M., Vane J. R., Mediators produced by the endothelial cell. Hypertension 1988 12 6 530 548 2-s2.0-0024210824
32. Harrison P., Mackie I., Mumford A., Briggs C., Liesner R., Winter M., Machin S., Guidelines for the laboratory investigation of heritable disorders of platelet function. British Journal of Haematology 2011 155 1 30 44 2-s2.0-80052574167 10.1111/j.1365-2141.2011.08793.x
33. Fukunaga K., Shimoyama T., Yamaji K., Yamane S., Sueoka A., Nosé Y., In vitro comparison study of CD63 and CD62P expression after contacting leukocyte filters. Artificial Organs 1999 23 1 108 113 2-s2.0-0032907927 10.1046/j.1525-1594.1999.06284.x
34. Saad A. A., Ismail E. A., Darwish Y. W., Nasr H. A., Hassan A. R., Bedeer I., Alfons M. A., P latelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation. Clinical and Applied Thrombosis/Hemostasis 2012 18 249 257
35. Shattil S. J., Cunningham M., Hoxie J. A., Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987 70 1 307 315 2-s2.0-0023185062
36. Ginsberg M. H., Frelinger A. L., Lam S. C.-T., Forsyth J., McMillan R., Plow E. F., Shattil S. J., Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 1990 76 10 2017 2023 2-s2.0-0025222435
37. Parguina A. F., Rosa I., Garcia A., P roteomics applied to the study of platelet- related diseases: aiding the discovery of novel platelet biomarker s and drug targets. Journal of Proteomics 2012 76 275 286
38. Arias-Salgado E. G., Larrucea S., Butta N., Fernández D., García-Muñoz S., Parrilla R., Ayuso M. S., Variations in platelet protein associated with arterial thrombosis. Thrombosis Research 2008 122 5 640 647 2-s2.0-49549115322 10.1016/j.thromres.2008.01.017
39. Banfi C., Brioschi M., Marenzi G., De Metrio M., Camera M., Mussoni L., Tremoli E., Proteome of platelets in patients with coronary artery disease. Experimental Hematology 2010 38 5 341 350 2-s2.0-77951480415 10.1016/j.exphem.2010.03.001
40. Sharathkumar A. A., Shapiro A., Platelet function disorders. Treatment For Hemophilia 2008 19
41. McNamara C. A., Sarembock I. J., Gimple L. W., Fenton J. W. II, Coughlin S. R., Owens G. K., Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. Journal of Clinical Investigation 1993 91 1 94 98 2-s2.0-0027492461
42. Griffin C. T., Srinivasan Y., Zheng Y.-W., Huang W., Coughlin S. R., A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 2001 293 5535 1666 1670 2-s2.0-0035979691 10.1126/science.1061259
43. Connolly A. J., Lshihara H., Kahn M. L., Farese R. V. Jr., Coughlin S. R., Role of the thrombin receptor an development and evidence for a second receptor. Nature 1996 381 6582 516 519 2-s2.0-0030008312
44. Harrison P., P latelet function analysis. Blood Reviews 2005 19 111 123
45. Kisucka J., Butterfield C. E., Duda D. G., Eichenberger S. C., Saffaripour S., Ware J., Ruggeri Z. M., Jain R. K., Folkman J., Wagner D. D., Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proceedings of the National Academy of Sciences of the United States of America 2006 103 4 855 860 2-s2.0-32244433234 10.1073/pnas.0510412103
46. Paidas M. J., Haut M. J., Lockwood C. J., Platelet disorders in pregnancy: implications for mother and fetus. Mount Sinai Journal of Medicine 1994 61 5 389 403 2-s2.0-0028113320
47. Clements J. L., Lee J. R., Gross B., Yang B., Olson J. D., Sandra A., Watson S. P., Lentz S. R., Koretzky G. A., Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. Journal of Clinical Investigation 1999 103 1 19 25 2-s2.0-0345654297
48. Hayden M. R., Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. Journal of the Pancreas 2002 3 5 126 138 2-s2.0-0036717212
49. Parmar D., Vidja K., Ghugare B., Impact of duration of diabetes and age: on lipid profile and glycaemic control in type 2 diabetic patients. Journal of International Medical Research 2013 2 1 69 72
50. Cade W. T., Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy 2008 88 11 1322 1335 2-s2.0-55849133043 10.2522/ptj.20080008
51. Lamon-Fava S., Wilson P. W. F., Schaefer E. J., Impact of body mass index on coronary heart disease risk factors in men and women: the Framingham Offspring Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 12 1509 1515 2-s2.0-0030454116
52. Chakraborty A., Bhattacharyya M., Diabetes, hypertension and cardiovascular disease-an unsolved enigma. Phytotherapy in the Management of Diabetes and Hypertension 2012 85 119
53. Saha A., Adak S., Chowdhury S., Bhattacharyya M., Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clinica Chimica Acta 2005 361 1-2 141 149 2-s2.0-25644439968 10.1016/j.cccn.2005.05.018
54. Adak S., Chowdhury S., Bhattacharyya M., Dynamic and electrokinetic behavior of erythrocyte membrane in diabetes mellitus and diabetic cardiovascular disease. Biochimica et Biophysica Acta 2008 1780 2 108 115 2-s2.0-38749086003 10.1016/j.bbagen.2007.10.013
55. Hughes A., McVerry B. A., Wilkinson L., Goldstone A. H., Lewis D., Bloom A., Diabetes, a hypercoagulable state? Haemostatic variables in newly diagnosed type 2 diabetic patients. Acta Haematologica 1983 69 4 254 259 2-s2.0-0020656731
56. Rosove M. H., Frank H. J. L., Harwig S. S. L., Plasma β -thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Diabetes Care 1984 7 2 174 179 2-s2.0-0021275512
57. de Cristofaro R., Rocca B., Vitacolonna E., Falco A., Marchesani P., Ciabattoni G., Landolfi R., Patrono C., Daví G., Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. Journal of Thrombosis and Haemostasis 2003 1 2 250 256 2-s2.0-0141450395 10.1046/j.1538-7836.2003.00072.x
58. Mayfield R. K., Halushka P. V., Wohltmann H. J., Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes 1985 34 11 1127 1133 2-s2.0-0022359246
59. Halushka P. V., Mayfield R., Wohltmann H. J., Rogers R. C., Goldberg A. K., McCoy S. A., Loadholt C. B., Colwell J. A., Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes 1981 30 2 44 48 2-s2.0-0019754096
60. Tomaselli L., Cerletti C., de Gaetano G., Notarbartolo A., Davi G., Pupillo M., Normal platelet function, but increased platelet activation in vivo in diabetic patients. Thrombosis and Haemostasis 1990 64 4 604 2-s2.0-0025606071
61. Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A., Increased platelet thromboxane synthesis in diabetes mellitus. Journal of Laboratory and Clinical Medicine 1981 97 1 87 96 2-s2.0-0019382703
62. McDonald J. W. D., Dupre J., Rodger N. W., Champion M. C., Webb C. D., Ali M., Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thrombosis Research 1982 28 6 705 712 2-s2.0-0020359307
63. Davi G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., Patrono C., Thromboxane biosynthesis and platelet function in type II diabetes mellitus. The New England Journal of Medicine 1990 322 25 1769 1774 2-s2.0-0025282786
64. Davì G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., Pennese E., Vitacolonna E., Bucciarelli T., Costantini F., Capani F., Patrono C., In vivo formation of 8-iso-prostaglandin and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999 99 2 224 229 2-s2.0-0032905015
65. Winocour P. D., Bryszewska M., Watala C., Rand M. L., Epand R. M., Kinlough-Rathbone R. L., Packham M. A., Mustard J. F., Reduced membrane fluidity in platelets from diabetic patients. Diabetes 1990 39 2 241 244 2-s2.0-0025099008
66. Winocour P. D., Watala C., Kinglough-Rathbone R. L., Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects. Thrombosis and Haemostasis 1992 67 5 567 571 2-s2.0-0026522345
67. Winocour P. D., Watala C., Perry D. W., Kinlough-Rathbone R. L., Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Thrombosis and Haemostasis 1992 68 5 577 582 2-s2.0-0026437818
68. Jinchuan Y., Zonggui W., Jinming C., Li L., Xiantao K., Upregulation of CD40-CD40 ligand system in patients with diabetes mellitus. Clinica Chimica Acta 2004 339 1-2 85 90 2-s2.0-0346366551 10.1016/j.cccn.2003.09.007
69. Tschoepe D., Roesen P., Kaufmann L., Schauseil S., Kehrel B., Ostermann H., Gries F. A., Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. European Journal of Clinical Investigation 1990 20 2 166 170 2-s2.0-0025214340
70. Tschoepe D., Driesch E., Schwippert B., Nieuwenhuis H.-K., Gries F. A., Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 1995 44 8 890 894 2-s2.0-0029135157
71. Jilma B., Fasching P., Ruthner C., Rumplmayr A., Ruzicka S., Kapiotis S., Wagner O. F., Eichler H.-G., Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thrombosis and Haemostasis 1996 76 3 328 332 2-s2.0-0029829853
72. Eibl N., Krugluger W., Streit G., Schrattbauer K., Hopmeier P., Schernthaner G., Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes. European Journal of Clinical Investigation 2004 34 3 205 209 2-s2.0-1642565073 10.1111/j.1365-2362.2004. 01320.x
73. Laghrissi-Thode F., Wagner W. R., Pollock B. G., Johnson P. C., Finkel M. S., Elevated platelet factor 4 and β -thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biological Psychiatry 1997 42 4 290 295 2-s2.0-0030847087 10.1016/S0006-3223(96)00345-9
74. Thompson S. G., Kienast J., Pyke S. D. M., Haverkate F., van de Loo J. C. W., Luscher E. F., Boissel J. P., Brakman P., Julian D. G., Prentice C. R. M., Verstraete M., Haverkate F., Bricaud H., Duckert F., Hugenholtz P. G., Lubsen J., Muller U. S., Breithardt G., Brochier M., Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. The New England Journal of Medicine 1995 332 10 635 641 2-s2.0-0028909230 10.1056/NEJM199503093321003
75. Balestrieri M. L., Servillo L., Esposito A., D'Onofrio N., Giovane A., Casale R., Barbieri M., Paolisso P., Rizzo M. R., Paolisso G., Marfella R., Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing S IRT1 signalling via platelet-activating factor receptor activation. Diabetologia 2013 56 162 172
76. Fatini C., Sticchi E., Bolli P., Marcucci R., Giusti B., Paniccia R., Gori A. M., Gensini G. F., Abbate R., Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 1 11 17 2-s2.0-78751611887 10.1016/j.numecd.2009.07.001
77. Williams M. S., Weiss E. J., Sabatine M. S., Simon D. I., Bahou W. F., Becker L. C., Parise L. V., Dauerman H. L., French P. A., Smyth S. S., Becker R. C., Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 12 2372 2384 2-s2.0-78650362947 10.1161/ATVBAHA.110.218131
78. Calverley D. C., Baldermann L. V., Moran K., Chen N. N., Mcfann K., Platelet Fc γ RIIA expression is associated with the 2 integrin C807T gene polymorphism in type 2 diabetes. Platelets 2006 17 2 78 83 2-s2.0-31544482452 10.1080/09537100500260865
79. Born G. V., Cross M. J., The aggregation of blood platelets. The Journal of physiology 1963 168 178 195 2-s2.0-78651139188
80. Cardinal D. C., Flower R. J., The electronic aggregometer: a novel device for assessing platelet behavior in blood. Journal of Pharmacological Methods 1980 3 2 135 158 2-s2.0-0018855854 10.1016/0160-5402(80)90024-8
81. Satoh K., Ozaki Y., Kume S., Detection of platelet aggregates using light scattering. Rinsho Byori 1995 43 5 426 431 2-s2.0-0029300347
82. Coller B. S., Lang D., Scudder L. E., Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 1997 95 4 860 867 2-s2.0-0031058513
83. Despotis G. J., Levine V., Filos K. S., Santoro S. A., Joist J. H., Spitznagel E., Goodnough L. T., Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 1996 85 6 1311 1323 2-s2.0-0030461052 10.1097/00000542-199612000- 00012
84. Kundu S. K., Heilmann E. J., Sio R., Garcia C., Davidson R. M., Ostgaard R. A., Description of an in vitro platelet function analyzer-PFA-100. Seminars in Thrombosis and Hemostasis 1995 21 supplement 2 106 112 2-s2.0-0029011142
85. Nicholson N. S., Panzer-Knodle S. G., Haas N. F., Taite B. B., Szalony J. A., Page J. D., Feigen L. P., Lansky D. M., Salyers A. K., Assessment of platelet function assays. American Heart Journal 1998 135 5 S170 S178 2-s2.0-0031837219
86. Li C. K. N., Hoffmann T. J., Hsieh P.-Y., Malik S., Watson W., Xylum CSA: automated system for assessing hemostasis in simulated vascular flow. Clinical Chemistry 1997 43 9 1788 1790 2-s2.0-0030609947
87. Mallett S. V., Cox D. J. A., Thrombelastography. British Journal of Anaesthesia 1992 69 3 307 313 2-s2.0-0026698019
88. Tschoepe D., The activated megakaryocyte-platelet-system in vascular disease: focus on diabetes. Seminars in Thrombosis and Hemostasis 1995 21 2 152 160 2-s2.0-0029027376
89. Tavassoli M., Megakaryocyte-platelet axis and the process of platelet formation and release. Blood 1980 55 4 537 545 2-s2.0-0019003217
90. Martin J. F., Bath P. M. W., Burr M. L., Influence of platelet size on outcome after myocardial infarction. The Lancet 1991 338 8780 1409 1411 2-s2.0-0025720068 10.1016/0140-6736(91)92719-I
91. 2+ homeostasis in diabetes mellitus. American Journal of Physiology-Heart and Circulatory Physiology 2001 280 4 H1480 H1489 2-s2.0-0035008904
92. Nadler J. L., Malayan S., Luong H., Shaw S., Natarajan R. D., Rude R. K., Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992 15 7 835 841 2-s2.0-0026752048
93. Ceriello A., Giacomello R., Stel G., Motz E., Taboga C., Tonutti L., Pirisi M., Falleti E., Bartoli E., Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Diabetes 1995 44 8 924 928 2-s2.0-0029131083
94. Guo X., Wu J., Du J., Ran J., Xu J., Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential. Platelets 2009 20 588 593
95. Chakraborty A., Chowdhury S., Bhattacharyya M., Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Research and Clinical Practice 2011 93 1 56 62 2-s2.0-79960561967 10.1016/j.diabres.2010.11.030
96. Chakraborty A., Karmakar T., Chowdhury S., Bhattacharyya M., Effect of Metformin on pathological indices related to cardiovascular disease in diabetes. The American Journal of Bio-pharmacology Biochemistry and Life Sciences 2012 1 53 64
97. Collier A., Watson H. H. K., Patrick A. W., Ludlam C. A., Clarke B. F., Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabete et Metabolisme 1989 15 6 420 425 2-s2.0-0024809869
98. Gregorio F., Ambrosi F., Manfrini S., Velussi M., Carle F., Testa R., Merante D., Filipponi P., Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin. Diabetic Medicine 1999 16 12 1016 1024 2-s2.0-0033368928 10.1046/j.1464-5491.1999.00201.x
99. Gargiulo P., Caccese D., Pignatelli P., Brufani C., De Vito F., Marino R., Lauro R., Violi F., Di Mario U., Sanguigni V., Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes/Metabolism Research and Reviews 2002 18 2 156 159 2-s2.0-0036255463 10.1002/dmrr.282
100. Grant P. J., Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes and Metabolism 2003 29 4 S6 S44 2-s2.0-18144451494
101. Jennings P. E., Vascular benefits of gliclazide beyond glycemic control. Metabolism 2000 49 10 17 20 2-s2.0-0033787627
102. Colwell J. A., Introduction: oral treatment of diabetes mellitus: the contribution of gliclazide. American Journal of Medicine 1991 90 1S 2S 2-s2.0-0025816686
103. Itoh M., Omi H., Okouchi M., Imaeda K., Shimizu M., Fukutomi T., Okayama N., The mechanisms of inhibitory actions of gliclazide on neutrophils- endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration. Journal of Diabetes and its Complications 2003 17 1 22 26 2-s2.0-0037227962 10.1016/S1056-8727(01)00219-7
104. Hauner H., The mode of action of thiazolidinediones. Diabetes/Metabolism Research and Reviews 2002 18 supplement 2 S10 S15
105. Akbiyik F., Ray D. M., Gettings K. F., Blumberg N., Francis C. W., Phipps R. P., Human bone marrow megakaryocytes and platelets express PPAR γ and PPAR γ agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 2004 104 5 1361 1368 2-s2.0-4444363344 10.1182/blood-2004-03-0926
106. Sidhu J. S., Cowan D., Kaski J. C., Effects of Rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. American Journal of Cardiology 2004 94 2 151 156 2-s2.0-3142608994 10.1016/j.amjcard.2004.03.051
107. 2+-ATPase and -calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation 2008 117 1 52 60 2-s2.0-37349104971 10.1161/CIRCULATIONAHA.107.719807
108. Kaplar M., Kappelmayer J., Veszpremi A., Szabo K., Udvardy M., The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets 2001 12 7 419 422 2-s2.0-0035185152 10.1080/09537100120078368
109. Randriamboavonjy V., Fleming I., Insulin, Insulin resistance, and platelet signaling in diabetes. Diabetes Care 2009 32 4 528 530 2-s2.0-65349085512 10.2337/dc08-1942
110. Fleming I., Schulz C., Fichtlscherer B., Kemp B. E., Fisslthaler B., Busse R., AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thrombosis and Haemostasis 2003 90 5 863 871 2-s2.0-0242690438
111. Randriamboavonjy V., Schrader J., Busse R., Fleming I., Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway. Journal of Experimental Medicine 2004 199 3 347 356 2-s2.0-1342321663 10.1084/jem.20030694
112. 2+ concentration in non-insulin-dependent diabetes mellitus. Diabetes Research 1991 18 2 89 94 2-s2.0-0026360468
113. 2+-ATPase by cAMP-dependent and tyrosine phosphorylation. Journal of Biological Chemistry 1997 272 24 15113 15119 2-s2.0-0030943549 10.1074/jbc.272.24.15113
114. Cella G., Scattolo N., Vio C., Stevanato F., Lavagnini T., Padovan D., Girolami A., Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease. Folia Haematologica 1986 113 5 646 654 2-s2.0-0022969588
115. Sacchi S., Curci G., Piccinini L., Cucci F., Messerotti A., Roncaia R., Benedetti P. G., P latelet alpha granule release in diabetes mellitus. Scandinavian Journal of Clinical & Laboratory Investigation 1985 45 165 168
116. Henn V., Steinbach S., Büchner K., Presek P., Kroczek R. A., The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001 98 4 1047 1054 2-s2.0-0035883087 10.1182/blood.V98.4.1047
117. Gisinger C., Jeremy J., Speiser P., Mikhailidis D., Dandona P., Schernthaner G., Effect of vitamin E supplementation on platelet thromboxane A2 production in Type I diabetic patients. Double-blind crossover trial. Diabetes 1988 37 9 1260 1264 2-s2.0-0024260831
118. Sacco M., Pellegrini F., Roncaglioni M. C., Avanzini F., Tognoni G., Nicolucci A., Primary prevention of cardiovascular events with low dose aspirin and vitamin E in type 2 diabetic patients: results of the Pimary Prevention Project (PPP) trial. Diabetes Care 2003 26 12 3264 3272 2-s2.0-0345411332 10.2337/diacare.26.12.3264
119. Chung I., Lip G. Y. H., Platelets and heart failure. European Heart Journal 2006 27 22 2623 2631 2-s2.0-33750900231 10.1093/eurheartj/ehl305
120. Mehta J., Mehta P., Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside. Circulation 1979 60 3 497 503 2-s2.0-0018646893
121. Lip G. Y. H., Lowe G. D. O., Metcalfe M. J., Rumley A., Dunn F. G., Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. American Journal of Cardiology 1995 76 7 453 458 2-s2.0-0029068645 10.1016/S0002-9149(99)80129-5
122. Chung I., Choudhury A., Lip G. Y. H., Platelet activation in acute, decompensated congestive heart failure. Thrombosis Research 2007 120 5 709 713 2-s2.0-34547951664 10.1016/j.thromres.2007.01.003
123. Shah A., Passacquale G., Gkaliagkousi E., Ritter J., Ferro A., Platelet nitric oxide signalling in heart failure: role of oxidative stress. Cardiovascular Research 2011 91 4 625 631 2-s2.0-80052015789 10.1093/cvr/cvr115
124. Boccardo P., Remuzzi G., Galbusera M., Platelet dysfunction in renal failure. Seminars in Thrombosis and Hemostasis 2004 30 5 579 589 2-s2.0-7044239110 10.1055/s-2004-835678
125. Kaw D., Malhotra D., Platelet dysfunction and end-stage renal disease. Seminars in Dialysis 2006 19 4 317 322 2-s2.0-33746255918 10.1111/j.1525-139X. 2006.00179.x
126. Belloc C., Lu H., Soria C., Fridman R., Legrand Y., Menashi S., The effects of platelets on invasiveness and protease production of human mammary tumor cells. International Journal of Cancer 1995 60 3 413 417 2-s2.0-0028985039
127. Lewalle J. M., Castronovo V., Goffinet G., Foidart J. M., Malignant cell attachment to endothelium of ex vivo perfused human umbilical vein. Modulation by platelets, plasma and fibronectin. Thrombosis Research 1991 62 4 287 298 2-s2.0-0025810842 10.1016/0049-3848(91)90149-Q
128. Haralabopoulos G. C., Grant D. S., Kleinman H. K., Maragoudakis M. E., Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. American Journal of Physiology-Cell Physiology 1997 273 1 C239 C245 2-s2.0-0030817878
129. Bambace N. M., Holmes C. E., The platelet contribution to cancer progression. Journal of Thrombosis and Haemostasis 2011 9 2 237 249 2-s2.0-79251577730 10.1111/j.1538-7836.2010.04131.x
130. Jain S., Harris J., Ware J., P latelets: linking hemostasis and cancer. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 2362 2367
131. Freedman J. E., Thrombin, thrombomodulin, and extracellular signal-regulated kinases regulating cellular proliferation. Circulation Research 2001 88 7 651 653 2-s2.0-0035853413
132. Ruf W., Mueller B. M., Thrombin generation and the pathogenesis of cancer. Seminars in Thrombosis and Hemostasis 2006 32 supplement 1 61 68
133. Catricala S., Torti M., Ricevuti G., A lzheimer disease and platelets: how's that relevant. Immunity & Ageing 2012 9 20
134. Iarlori C., Gambi D., Gambi F., Lucci I., Feliciani C., Salvatore M., Reale M., Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease. Experimental Gerontology 2005 40 7 605 611 2-s2.0-23044465288 10.1016/j.exger.2005.04.007
135. Zubenko G. S., Cohen B. M., Reynolds C. F. III, Boller F., Malinakova I., Keefe N., Platelet membrane fluidity in Alzheimer's disease and major depression. American Journal of Psychiatry 1987 144 7 860 868 2-s2.0-0023236375
136. Prodan C. I., Ross E. D., Stoner J. A., Cowan L. D., Vincent A. S., Dale G. L., Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011 76 3 247 252 2-s2.0-78751608012 10.1212/WNL.0b013e3182074bd2
137. Amitrano L., Guardascione M. A., Brancaccio V., Balzano A., Coagulation disorders in liver disease. Seminars in Liver Disease 2002 22 1 83 96 2-s2.0-0036123632
138. Mammen E. F., Coagulation abnormalities in liver disease. Hematology/Oncology Clinics of North America 1992 6 6 1247 1258 2-s2.0-0026467337
139. McCormick P. A., Murphy K. M., Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Best Practice and Research 2000 14 6 1009 1031 2-s2.0-0034500502 10.1053/bega.2000.0144
140. Hugenholtz G. G. C., Porte R. J., Lisman T., The platelet and platelet function testing in liver disease. Clinics in Liver Disease 2009 13 1 11 20 2-s2.0-58149503881 10.1016/j.cld.2008.09.010
141. Maruyama T., Murata S., Takahashi K., Tamura T., Nozaki R., Ikeda N., Fukunaga K., Oda T., Sasaki R., Ohkohchi N., Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. The Tohoku Journal of Experimental Medicine 2013 229 213 220
142. Panasiuk A., Prokopowicz D., Zak J., Matowicka-Karna J., Osada J., Wysocka J., Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of β -thromboglobulin and platelet factor-4. Hepato-Gastroenterology 2001 48 39 818 822 2-s2.0-0034930778